Press releases | WebDisclosure

Basculer en Français

9567	Companies
189096	Keywords
120785	Articles
100890	Press releases

Home
Press releases

PRESS RELEASE

published on 01/29/2024 at 13:00, 1 year 10 months ago

Komet Sales and Axerrio Combine to Expand Their Leading B2B Floral E-Commerce Network Across Europe and the Americas
Komet Sales, the leading software provider for the floral industry in the Americas, announces merger with Axerrio, a leading software provider for the floral industry in Europe. The merger aims to benefit customers by increasing access to new features and an expanded network of buyers and sellers

Merger Komet Sales Axerrio Floral Industry E-commerce Networks
PRESS RELEASE

published on 01/29/2024 at 13:00, 1 year 10 months ago

Cotec Holdings Corp. Provides Operational Overview and 2024 Key Targets
CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) reports 2023 operational highlights and 2024 targets. Initiated strategic investments, completed name change, and listed on TSXV. Focus on sustainable resource production and transformative technologies

2024 Targets CoTec Holdings Corp TSXV:CTH OTCQB:CTHCF 2023 Operational Highlights
PRESS RELEASE

published on 01/29/2024 at 13:00, 1 year 10 months ago

Pulsar Provides Operational Update for the Topaz Helium Project
Pulsar Helium Inc. provides an update on the mobilisation of the Capstar drill rig for the Jetstream #1 appraisal well. CEO and GM on site. IPO financing details also disclosed

Pulsar Helium Inc. Appraisal Well Capstar Drill Rig Jetstream #1 IPO Financing
PRESS RELEASE

published on 01/29/2024 at 12:30, 1 year 10 months ago

Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
NanoViricides, Inc. successfully completes Phase 1a/1b Clinical Trial of NV-CoV-2, reporting excellent safety and broad-spectrum antiviral activity of NV-387 against various respiratory viruses including Coronaviruses and RSV

NV-387 NanoViricides Inc NV-CoV-2 Phase 1a/1b Clinical Trial Antiviral Therapy
PRESS RELEASE

published on 01/29/2024 at 12:22, 1 year 10 months ago

EQS-Adhoc: Enapter AG: Foundation of a joint venture with WOLONG Group
Enapter AG and WOLONG Group form joint venture to produce AEM electrolyser products locally in China, expanding cooperation and tapping into Chinese market potential

Joint Venture Enapter AG WOLONG Group AEM Electrolyser Chinese Market
PRESS RELEASE

published on 01/29/2024 at 12:15, 1 year 10 months ago

EQS-Adhoc: Bilfinger SE: EBITA margin and free cash flow in financial year 2023 exceeded outlook
Bilfinger SE reports EBITA margin for 2023 financial year exceeded outlook at 4.3% and free cash flow expected to be € 122 million, surpassing outlook by € 42 million. Revenue to be within outlook range. Mid-term targets confirmed

Financial Results Bilfinger SE EBITA Margin Free Cash Flow Outlook
PRESS RELEASE

published on 01/29/2024 at 11:11, 1 year 10 months ago

EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Carl Zeiss Meditec AG has approved a share buyback program of up to €150m, representing 1.7% of share capital, starting on 9 February 2024. The company may discontinue the program at any time

Share Buyback Program Carl Zeiss Meditec AG €150m XETRA Trading Stock Market Price
PRESS RELEASE

published on 01/29/2024 at 11:03, 1 year 10 months ago

New evidence informs risk factors, diagnosis and care of patients with CVT stroke
American Heart Association releases a new scientific statement emphasizing the need to increase awareness of cerebral venous thrombosis (CVT) to improve recognition and initiate prompt medical treatment. The statement reviews the latest evidence and updates recommendations for diagnosing and managing CVT, focusing on advancements in treatment approaches

American Heart Association Scientific Statement Cerebral Venous Thrombosis CVT Stroke Risk Factors
PRESS RELEASE

published on 01/29/2024 at 11:02, 1 year 10 months ago

Original-Research: Avemio AG (von GBC AG): Kaufen
Avemio AG veröffentlicht vorläufige Zahlen für das abgelaufene Geschäftsjahr 2023 und bestätigt das Kauf-Rating trotz Umsatz- und Ergebnisrückgang. Neue Prognose und Kursziel von 32,00 EUR für 2024. Solide Kapitalausstattung und M&A-Wachstum geplant

Avemio AG Geschäftsjahr 2023 Kauf-Rating Prognose Reduziert M&A-Wachstum
PRESS RELEASE

published on 01/29/2024 at 11:01, 1 year 10 months ago

Original-Research: Avemio AG (von GBC AG): BUY
Avemio AG's sales and earnings for 2023 fell short of expectations, leading to reduced forecasts and a target price adjustment to 32.00 EUR. Despite challenges, the company maintains a solid capital base and plans for M&A growth

Earnings Forecast Avemio AG GBC AG Sales Decline Target Price Adjustment

Accesswire

Published on 12/22/2025 at 15:00, 2 hours ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 2 hours 20 minutes ago

Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 2 hours 30 minutes ago

Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 3 hours ago

Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 3 hours ago

PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 16:28, 31 minutes ago

EQS-Adhoc: Gerresheimer AG: Gerresheimer AG corrects comprehensively revenues from bill-and-hold agreements
Published on 12/22/2025 at 15:50, 1 hour 9 minutes ago

Original-Research: Rock Tech Lithium Inc. (von First Berlin Equity Research GmbH): Buy
Published on 12/22/2025 at 15:27, 1 hour 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/22/2025 at 15:26, 1 hour 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 12/22/2025 at 15:26, 1 hour 34 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc

Les Echos

Published on 12/22/2025 at 15:00, 2 hours ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/22/2025 at 15:00, 2 hours ago

Capital increase through exercise of subscription rights
Published on 12/22/2025 at 09:18, 7 hours 41 minutes ago

GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/22/2025 at 09:18, 7 hours 41 minutes ago

GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025
Published on 12/19/2025 at 21:57, 2 days 19 hours ago

Mise à disposition du document d’enregistrement universel

View all LES ECHOS COMFI WIRE